Energy expenditure and bone formation share a common sensitivity to AP-1 transcription in the hypothalamus

Journal of Bone and Mineral Research

Volumn 27, Issue 8, 2012, Pages 1649-1658

  Rowe, Glenn C ^a,b,f   Vialou, Vincent ^c   Sato, Kazusa ^a,b   Saito, Hiroaki ^a,b   Yin, Min ^a,b   Green, Thomas A ^c,d,e   Lotinun, Sutada ^a,b   Kveiborg, Marie ^a,b,e   Horne, William C ^a,b   Nestler, Eric J ^c   Baron, Roland ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AP 1; BONE FORMATION; ENERGY EXPENDITURE; HYPOTHALAMUS

Indexed keywords

FAT; PARVOVIRUS VECTOR; TRANSCRIPTION FACTOR FOSB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; CONTROLLED STUDY; ENERGY EXPENDITURE; GENE OVEREXPRESSION; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; OSSIFICATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION;

ANIMALS; BODY WEIGHT; DEPENDOVIRUS; ENERGY METABOLISM; GENES, DOMINANT; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; ORGAN SIZE; OSTEOGENESIS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 84864148119     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1618     Document Type: Article

References (49)

1. Karsenty G, Oury F., The central regulation of bone mass, the first link between bone remodeling and energy metabolism. J Clin Endocrinol Metab. 2010; 95 (11): 4795-801.
2. Rosen CJ, Klibanski A., Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med. 2009; 122 (5): 409-14.
3. Mayer J, Thomas DW., Regulation of food intake and obesity. Science. 1967; 156 (773): 328-37.
4. Horvath TL., The hardship of obesity: a soft-wired hypothalamus. Nat Neurosci. 2005; 8 (5): 561-5.
5. He W, Lam TK, Obici S, Rossetti L., Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat Neurosci. 2006; 9 (2): 227-33.
6. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G., Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000; 100 (2): 197-207.
7. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H., Hypothalamic Y2 receptors regulate bone formation. J Clin Invest. 2002; 109 (7): 915-21.
8. Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H, Gardiner EM., Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. J Bone Miner Res. 2005; 20 (10): 1851-7.
9. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G., Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005; 434 (7032): 514-20.
10. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, Inose H, Ida T, Mieda M, Takeuchi Y, Fukumoto S, Fujita T, Kato S, Kangawa K, Kojima M, Shinomiya K, Takeda S., Central control of bone remodeling by neuromedin U. Nat Med. 2007; 13 (10): 1234-40.
11. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R., Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med. 2000; 6 (9): 985-90.
12. Sims NA, Sabatakos G, Chen JS, Kelz MB, Nestler EJ, Baron R., Regulating DeltaFosB expression in adult Tet-Off-DeltaFosB transgenic mice alters bone formation and bone mass. Bone. 2002; 30 (1): 32-9.
13. McClung CA, Nestler EJ., Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci. 2003; 6 (11): 1208-15.
14. Renthal W, Kumar A, Xiao G, Wilkinson M, Covington HE 3rd, Maze I, Sikder D, Robison AJ, LaPlant Q, Dietz DM, Russo SJ, Vialou V, Chakravarty S, Kodadek TJ, Stack A, Kabbaj M, Nestler EJ., Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron. 2009; 62 (3): 335-48.
15. Kveiborg M, Sabatakos G, Chiusaroli R, Wu M, Philbrick WM, Horne WC, Baron R., DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol Cell Biol. 2004; 24 (7): 2820-30.
16. Rowe GC, Choi CS, Neff L, Horne WC, Shulman GI, Baron R., Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice. Endocrinology. 2009; 150 (1): 135-43.
17. Zhang SX, Zhang JP, Fletcher DL, Zoeller RT, Sun GY., In situ hybridization of mRNA expression for IP3 receptor and IP3-3-kinase in rat brain after transient focal cerebral ischemia. Brain Res Mol Brain Res. 1995; 32 (2): 252-60.
18. Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, Shaw-Lutchman T, Berton O, Sim-Selley LJ, Dileone RJ, Kumar A, Nestler EJ., An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci. 2006; 9 (2): 205-11.
19. Sabatakos G, Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R, Philbrick WM, Baron R., Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. J Bone Miner Res. 2008; 23 (5): 584-95.
20. Peakman MC, Colby C, Perrotti LI, Tekumalla P, Carle T, Ulery P, Chao J, Duman C, Steffen C, Monteggia L, Allen MR, Stock JL, Duman RS, McNeish JD, Barrot M, Self DW, Nestler EJ, Schaeffer E., Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine. Brain Res. 2003; 970 (1-2): 73-86.
21. Luther J, Driessler F, Megges M, Hess A, Herbort B, Mandic V, Zaiss MM, Reichardt A, Zech C, Tuckermann JP, Calkhoven CF, Wagner EF, Schett G, David JP., Elevated Fra-1 expression causes severe lipodystrophy. J Cell Sci. 2011; 124 (Pt 9): 1465-76.
22. Brown JR, Ye H, Bronson RT, Dikkes P, Greenberg ME., A defect in nurturing in mice lacking the immediate early gene fosB. Cell. 1996; 86 (2): 297-309.
23. Chocyk A, Czyrak A, Wedzony K., Acute and repeated cocaine induces alterations in FosB/DeltaFosB expression in the paraventricular nucleus of the hypothalamus. Brain Res. 2006; 1090 (1): 58-68.
24. Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J, Kelley KW, Dantzer R, Castanon N., Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology. 2007; 32 (5): 516-31.
25. Dyck DJ, Heigenhauser GJ, Bruce CR., The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf). 2006; 186 (1): 5-16.
26. Ahima RS, Qi Y, Singhal NS., Adipokines that link obesity and diabetes to the hypothalamus. Prog Brain Res. 2006; 153: 155-74.
27. Ahima RS, Qi Y, Singhal NS, Jackson MB, Scherer PE., Brain adipocytokine action and metabolic regulation. Diabetes. 2006; 55 (Suppl 2): S145-54.
28. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G., The molecular clock mediates leptin-regulated bone formation. Cell. 2005; 122 (5): 803-15.
29. Cornish J, Callon KE, Mountjoy KG, Bava U, Lin JM, Myers DE, Naot D, Reid IR., Alpha-melanocyte-stimulating hormone is a novel regulator of bone. Am J Physiol Endocrinol Metab. 2003; 284 (6): E1181-90.
30. Sun L, Davies TF, Blair HC, Abe E, Zaidi M., TSH and bone loss. Ann NY Acad Sci. 2006; 1068: 309-18.
31. Daval M, Foufelle F, Ferre P., Functions of AMP-activated protein kinase in adipose tissue. J Physiol. 2006; 574 (Pt 1): 55-62.
32. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M., FSH directly regulates bone mass. Cell. 2006; 125 (2): 247-60.
33. Olney RC., Regulation of bone mass by growth hormone. Med Pediatr Oncol. 2003; 41 (3): 228-34.
34. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G., Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002; 111 (3): 305-17.
35. Kveiborg M, Chiusaroli R, Sims NA, Wu M, Sabatakos G, Horne WC, Baron R., The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels. Endocrinology. 2002; 143 (11): 4304-9.
36. Cornish J, Williams GA, Callon KE, Watson M, Lin J, Naot D, Wang Y, Xu A, Reid IR., Adiponectin, another link between fat and bone mass?. Bone. 2007; 40 (6): S117-S117.
37. Yen J, Wisdom RM, Tratner I, Verma IM., An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc Natl Acad Sci USA. 1991; 88 (12): 5077-81.
38. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF., Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol. 1993; 122 (3): 685-701.
39. Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler EJ., Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci. 1997; 17 (13): 4933-41.
40. Alibhai IN, Green TA, Potashkin JA, Nestler EJ., Regulation of fosB and DeltafosB mRNA expression: in vivo and in vitro studies. Brain Res. 2007; 1143: 22-33.
41. Ulery PG, Nestler EJ., Regulation of DeltaFosB transcriptional activity by Ser27 phosphorylation. Eur J Neurosci. 2007; 25 (1): 224-30.
42. Carle TL, Ohnishi YN, Ohnishi YH, Alibhai IN, Wilkinson MB, Kumar A, Nestler EJ., Proteasome-dependent and -independent mechanisms for FosB destabilization: identification of FosB degron domains and implications for DeltaFosB stability. Eur J Neurosci. 2007; 25 (10): 3009-19.
43. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ., DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res. 2004; 132 (2): 146-54.
44. Olausson P, Jentsch JD, Tronson N, Neve RL, Nestler EJ, Taylor JR., DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J Neurosci. 2006; 26 (36): 9196-204.
45. Sainsbury A, Lin S, McNamara K, Slack K, Enriquez R, Lee NJ, Boey D, Smythe GA, Schwarzer C, Baldock P, Karl T, Lin EJ, Couzens M, Herzog H., Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice. Mol Endocrinol. 2007; 21 (7): 1722-35.
46. Wortley KE, Garcia K, Okamoto H, Thabet K, Anderson KD, Shen V, Herman JP, Valenzuela D, Yancopoulos GD, Tschop MH, Murphy A, Sleeman MW., Peptide YY regulates bone turnover in rodents. Gastroenterology. 2007; 133 (5): 1534-43.
47. Chen J, Zhang Y, Kelz MB, Steffen C, Ang ES, Zeng L, Nestler EJ., Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: role of [Delta]FosB. J Neurosci. 2000; 20 (24): 8965-71.
48. Perrotti LI, Hadeishi Y, Ulery PG, Barrot M, Monteggia L, Duman RS, Nestler EJ., Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci. 2004; 24 (47): 10594-602.
49. Kelz MB, Chen J, Carlezon WA Jr, Whisler K, Gilden L, Beckmann AM, Steffen C, Zhang YJ, Marotti L, Self DW, Tkatch T, Baranauskas G, Surmeier DJ, Neve RL, Duman RS, Picciotto MR, Nestler EJ., Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature. 1999; 401 (6750): 272-6.